https://cosmosscholars.com/phms/index.php/ijnmr <p><strong>International Journal of Nuclear Medicine Research</strong> provides an authoritative setting for the publication of high quality internationally-relevant research with respect to the field of Nuclear Medicine.</p><p>Nuclear Medicine is crucial to early diagnosis and treatment of diseases that threaten human lives like coronary artery disease, brain illness and tumors etc. Nuclear medicine imaging studies are generally more organ- or tissue-specific (e.g.: lungs scan, heart scan, bone scan, brain scan, etc.) than those in conventional radiology imaging, which focus on a particular section of the body (e.g.: chest X-ray, abdomen/pelvis CT scan, head CT scan, etc.).</p>The journal aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, expert opinions and conference papers. Cosmos Schoalrs Publishing House en-US Int. J. of Nuclear Medicine Research 2408-9788 <h4>Policy for Journals/Articles with Open Access</h4>Authors who publish with this journal agree to the following terms:<br /><ol type="a"><ol type="a"><li>Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a <a href="http://creativecommons.org/licenses/by/3.0/" target="_new">Creative Commons Attribution License</a> that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</li></ol></ol><br /><ol type="a"><li>Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work</li></ol><h4>Policy for Journals / Manuscript with Paid Access</h4>Authors who publish with this journal agree to the following terms:<br /><ol type="a"><ol type="a"><li>Publisher retain copyright .</li></ol></ol><br /><ol type="a"><li>Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .</li></ol> https://cosmosscholars.com/phms/index.php/ijnmr/article/view/870 <p class="04-abstract"><strong>Abstract</strong>: Fluorine -18 Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/ computer tomography (CT)(F 18 FDG PET/CT) is used in staging of prostate cancer if Ga 68 PSMA is not available. Adrenal metastasis from prostate cancer is a rare phenomenon that is infrequently diagnosed incidentally during imaging. We report the first case of 65-year old patient diagnosed as poorly differentiated prostate adenocarcinoma presenting with adrenal metastases imaged using F- 18 FDG PET/CT.</p> Koramadai Karuppusamy Kamaleshwaran Stuart More Raghi Paramben Jose Ajit Sugunan Shinto Copyright (c) 2018-03-30 2018-03-30 5 1 1 3 https://cosmosscholars.com/phms/index.php/ijnmr/article/view/871 <p class="04-abstract"><strong>Abstract:</strong> A comparison of Technetium-99m and Fluorine-18 properties is carried out. Availability of both radionuclides is described. Radiation doses by their use in SPECT and PET procedures are analysed. Supply and costs of Technetium-99m and Fluorine-18 are compared. Various compounds of these radionuclides used in diagnosis by PET and SPECT are listed. Technetium-99 will continue as a main radionuclide used in diagnostic procedures in foreseeable future.</p> A. Mushtaq Copyright (c) 2018-03-30 2018-03-30 5 1 4 9 https://cosmosscholars.com/phms/index.php/ijnmr/article/view/872 <p class="04-abstract"><strong>Abstract:</strong> Renal cell Carcinoma (RCC) of the native kidney accounts for less than 5% of all malignancies found in transplant recipients. Owing to the rarity of this condition, there are only a number of documented case reports of patients who have undergone renal transplantation with RCC of the native kidney. Fluorine -18 Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/ computer tomography (CT) (F-18 FDG PET/CT) is used in the staging of high risk RCC or when conventional imaging is equivocal. The prognosis of metastatic RCC is poor .We report the first case of a 55 year old post renal transplant recipient diagnosed with RCC of the native kidney with liver and bone metastases imaged using F- 18 FDG PET/CT.</p> Koramadai Karuppusamy Kamaleshwaran Stuart More Raghi Paramben Jose Ajit Sugunan Shinto Copyright (c) 2018-03-30 2018-03-30 5 1 10 12